Your browser doesn't support javascript.
loading
Cortical Pathology in Vanishing White Matter.
Man, Jodie H K; van Gelder, Charlotte A G H; Breur, Marjolein; Okkes, Daniel; Molenaar, Douwe; van der Sluis, Sophie; Abbink, Truus; Altelaar, Maarten; van der Knaap, Marjo S; Bugiani, Marianna.
Afiliação
  • Man JHK; Department of Child Neurology, Emma Children's Hospital, Amsterdam University Medical Centers, VU University Amsterdam, 1081 HV Amsterdam, The Netherlands.
  • van Gelder CAGH; Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • Breur M; Molecular and Cellular Mechanisms, Amsterdam Neuroscience, 1081 HV Amsterdam, The Netherlands.
  • Okkes D; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, 3584 CS Utrecht, The Netherlands.
  • Molenaar D; Netherlands Proteomics Center, 3584 CS Utrecht, The Netherlands.
  • van der Sluis S; Department of Child Neurology, Emma Children's Hospital, Amsterdam University Medical Centers, VU University Amsterdam, 1081 HV Amsterdam, The Netherlands.
  • Abbink T; Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • Altelaar M; Molecular and Cellular Mechanisms, Amsterdam Neuroscience, 1081 HV Amsterdam, The Netherlands.
  • van der Knaap MS; Department of Child Neurology, Emma Children's Hospital, Amsterdam University Medical Centers, VU University Amsterdam, 1081 HV Amsterdam, The Netherlands.
  • Bugiani M; Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
Cells ; 11(22)2022 11 12.
Article em En | MEDLINE | ID: mdl-36429009
Vanishing white matter (VWM) is classified as a leukodystrophy with astrocytes as primary drivers in its pathogenesis. Magnetic resonance imaging has documented the progressive thinning of cortices in long-surviving patients. Routine histopathological analyses, however, have not yet pointed to cortical involvement in VWM. Here, we provide a comprehensive analysis of the VWM cortex. We employed high-resolution-mass-spectrometry-based proteomics and immunohistochemistry to gain insight into possible molecular disease mechanisms in the cortices of VWM patients. The proteome analysis revealed 268 differentially expressed proteins in the VWM cortices compared to the controls. A majority of these proteins formed a major protein interaction network. A subsequent gene ontology analysis identified enrichment for terms such as cellular metabolism, particularly mitochondrial activity. Importantly, some of the proteins with the most prominent changes in expression were found in astrocytes, indicating cortical astrocytic involvement. Indeed, we confirmed that VWM cortical astrocytes exhibit morphological changes and are less complex in structure than control cells. Our findings also suggest that these astrocytes are immature and not reactive. Taken together, we provide insights into cortical involvement in VWM, which has to be taken into account when developing therapeutic strategies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucoencefalopatias / Substância Branca Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucoencefalopatias / Substância Branca Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article